Magliocco Anthony
Magliocco Anthony
Dirección de correo verificada de - Página principal
Citado por
Citado por
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or …
JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ...
The lancet oncology 16 (2), 187-199, 2015
A large-scale study of the ultrawideband microwave dielectric properties of normal, benign and malignant breast tissues obtained from cancer surgeries
M Lazebnik, D Popovic, L McCartney, CB Watkins, MJ Lindstrom, J Harter, ...
Physics in medicine & biology 52 (20), 6093, 2007
Type I and II endometrial cancers: have they different risk factors?
VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ...
Journal of Clinical Oncology 31 (20), 2607-2618, 2013
A large-scale study of the ultrawideband microwave dielectric properties of normal breast tissue obtained from reduction surgeries
M Lazebnik, L McCartney, D Popovic, CB Watkins, MJ Lindstrom, J Harter, ...
Physics in medicine & biology 52 (10), 2637, 2007
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
S Kopetz, SL McDonough, VK Morris, HJ Lenz, AM Magliocco, CE Atreya, ...
Journal of Clinical Oncology 35 (4_suppl), 520-520, 2017
Long-term results of NRG oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell lung cancer
JD Bradley, C Hu, RR Komaki, GA Masters, GR Blumenschein, SE Schild, ...
Journal of Clinical Oncology 38 (7), 706, 2020
Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
EL Goode, MS Block, KR Kalli, RA Vierkant, W Chen, ZC Fogarty, ...
JAMA oncology 3 (12), e173290-e173290, 2017
An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging
S Drabycz, G Roldán, P De Robles, D Adler, JB McIntyre, AM Magliocco, ...
Neuroimage 49 (2), 1398-1405, 2010
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
WH Roa, S Azarmi, MHDK Al-Hallak, WH Finlay, AM Magliocco, ...
Journal of controlled release 150 (1), 49-55, 2011
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
C Yau, M Osdoit, M van der Noordaa, S Shad, J Wei, D de Croze, ...
The Lancet Oncology 23 (1), 149-160, 2022
Identification of nine new susceptibility loci for endometrial cancer
TA O’mara, DM Glubb, F Amant, D Annibali, K Ashton, J Attia, PL Auer, ...
Nature communications 9 (1), 3166, 2018
Suppression of ING1 expression in sporadic breast cancer
T Toyama, H Iwase, P Watson, H Muzik, E Saettler, A Magliocco, ...
Oncogene 18 (37), 5187-5193, 1999
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
AE Sijben, JB McIntyre, GB Roldán, JC Easaw, E Yan, PA Forsyth, ...
Journal of neuro-oncology 89, 97-103, 2008
Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer
EK Enwere, EN Kornaga, M Dean, TA Koulis, T Phan, M Kalantarian, ...
Modern Pathology 30 (4), 577-586, 2017
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
CT Williamson, E Kubota, JD Hamill, A Klimowicz, R Ye, H Muzik, M Dean, ...
EMBO molecular medicine 4 (6), 515-527, 2012
Association of event-free and distant recurrence–free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer …
D Yee, AM DeMichele, C Yau, C Isaacs, WF Symmans, KS Albain, ...
JAMA oncology 6 (9), 1355-1362, 2020
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors
LM Kmet, LS Cook, AM Magliocco
Cancer 97 (2), 389-404, 2003
Case–control study of the metabolic syndrome and metabolic risk factors for endometrial cancer
CM Friedenreich, RK Biel, DCW Lau, I Csizmadi, KS Courneya, ...
Cancer epidemiology, biomarkers & prevention 20 (11), 2384-2395, 2011
Characterization of large structural genetic mosaicism in human autosomes
MJ Machiela, W Zhou, JN Sampson, MC Dean, KB Jacobs, A Black, ...
The American Journal of Human Genetics 96 (3), 487-497, 2015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20